Photo
July 19, 2018
David Karow is Human Longevity’s recently named interim CEO. New leadership wants to open testing centers in new areas. Photos courtesy of Human Longevity
Stories this photo appears in:
After Turmoil, Human Longevity Sharpens Focus on Commercialization
GENOMICS: Exec Says Co. Has Cash, Runway to Next Phase
New leadership at Human Longevity is seeking to emerge from a tumultuous period of executive exodus and workforce reduction through a bid to bring its genomics-based testing center to a wider market.
